Treatment outcomes of ziv‐aflibercept for treatment‐naïve polypoidal choroidal vasculopathy

Publisher： John Wiley & Sons Inc

E-ISSN： 1755-3768|96|2|e258-e259

ISSN： 1755-375X

Source： ACTA OPHTHALMOLOGICA, Vol.96, Iss.2, 2018-03, pp. : e258-e259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

One‐year treatment outcomes of ziv‐aflibercept for treatment‐naïve macular oedema in branch retinal vein occlusion

By  

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. 2, 2018-03 ,pp. : e256-e257

John Wiley & Sons Inc

Access to resources Recommend Favorite

Polypoidal choroidal vasculopathy treatment options: A meta‐analysis

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 48, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of aflibercept for polypoidal choroidal vasculopathy in Caucasians

By  

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. 1, 2018-02 ,pp. : e94-e95

John Wiley & Sons Inc

Access to resources Recommend Favorite

Visual outcomes of polypoidal choroidal vasculopathy treated with intravitreal ranibizumab with or without photodynamic therapy

By  

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. 2, 2018-03 ,pp. : e254-e255

John Wiley & Sons Inc

Access to resources Recommend Favorite